{"id":1193,"date":"2026-10-04T21:18:16","date_gmt":"2026-10-04T21:18:16","guid":{"rendered":"https:\/\/muhammetozgehan.com\/medical-treatments-pharmacological-and-topical-solutions\/"},"modified":"2026-10-08T21:33:43","modified_gmt":"2026-10-08T21:33:43","slug":"medical-treatments-pharmacological-and-topical-solutions","status":"publish","type":"page","link":"https:\/\/muhammetozgehan.com\/en\/medical-treatments-pharmacological-and-topical-solutions\/","title":{"rendered":"Medical Treatments (Pharmacological and Topical Solutions)"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1193\" class=\"elementor elementor-1193 elementor-368\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f5ea282 e-flex e-con-boxed e-con e-parent\" data-id=\"f5ea282\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-93fab41 elementor-widget elementor-widget-html\" data-id=\"93fab41\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t<div class=\"medical-guide-page-wrapper\">\r\n    <!-- Sayfa \u00dcst\u00fc K\u00fcresel Ba\u015fl\u0131k & Logo Alan\u0131 -->\r\n    <div class=\"guide-hero\">\r\n        <div class=\"hero-title-wrapper\">\r\n            <div class=\"hero-logo-box\">\r\n                <img decoding=\"async\" src=\"https:\/\/muhammetozgehan.com\/wp-content\/uploads\/2026\/10\/logo-seffaf.png\" alt=\"Dr. Muhammet \u00d6zgehan Logo\" width=\"32\" height=\"32\" class=\"hero-inline-logo\" title=\"\">\r\n            <\/div>\r\n            <h2>Medical Hair Encyclopedia<\/h2>\r\n        <\/div>\r\n        <p class=\"guide-subtitle\">Dermatological pathologies and evidence-based clinical guidelines at international standards.<\/p>\r\n    <\/div>\r\n\r\n    <!-- Ana Makale Konteyneri -->\r\n    <article class=\"medical-article-card\">\r\n        <div class=\"article-header\">\r\n            <span class=\"article-category\">HAIR TREATMENTS & MEDICAL APPROACH<\/span>\r\n            <h1>Medical Treatments (Pharmacological and Topical Solutions) \u2013 Clinical Management Guide<\/h1>\r\n            <div class=\"author-meta-box\">\r\n                <p><strong>Prepared by:<\/strong> Dr. Muhammet \u00d6zgehan | Turkish Hair and Scalp Diseases Association<\/p>\r\n                <p class=\"compilation-note\"><em>This guide is compiled by Dr. Muhammet \u00d6zgehan in conjunction with current trichology literature.<\/em><\/p>\r\n            <\/div>\r\n        <\/div>\r\n\r\n        <!-- Hasta Bilgilendirme B\u00f6l\u00fcm\u00fc -->\r\n        <section class=\"patient-info-box\">\r\n            <h3>\ud83d\udccc Patient Information Section: What Do Medical Treatments Entail?<\/h3>\r\n            <p>Hair loss or a decrease in hair quality does not always necessitate surgical operations like hair transplantation. <strong>Medical treatments<\/strong>, applied in the early and middle stages of miniaturization (shrinking) when hair follicles have not yet completely lost their vitality, are the most fundamental methods for preserving hair and stopping hair loss. <\/p>\r\n            <ul class=\"styled-list\">\r\n                <li><strong>In Which Cases Are They Applied?:<\/strong> They are preferred in the early stages of male-pattern (Androgenetic Alopecia) or female-pattern (FPHL) hair loss, in cases of telogen effluvium (widespread shedding), and to improve the quality of hair strands.<\/li>\r\n                <li><strong>How Do They Work?:<\/strong> They increase capillary blood flow to the hair follicles, support follicle nourishment, and alleviate the negative pressure of hormones responsible for hair loss (e.g., DHT) on the follicles.<\/li>\r\n                <li><strong>When Are Results Achieved?:<\/strong> Due to the slow biological nature of the hair cycle, the first noticeable improvements and reduction in hair loss with medical treatments are generally observed between <strong>3 to 6 months<\/strong>.<\/li>\r\n            <\/ul>\r\n        <\/section>\r\n\r\n        <!-- 1. G\u00f6rsel: Minoksidil ve Finasterid \/ Dutasterid Mekanizmas\u0131 -->\r\n        <div class=\"medical-illustration-box\">\r\n            <img decoding=\"async\" src=\"https:\/\/muhammetozgehan.com\/wp-content\/uploads\/2026\/10\/dr-muhammet-ozgehan-minoksidil-finasterid-etki-mekanizmasi.png\" alt=\"Minoxidil, Finasteride, and Dutasteride Mechanisms of Action \u2013 Dr. Muhammet \u00d6zgehan\" title=\"\">\r\n            <p class=\"illustration-caption\">Figure 1: Minoxidil's effect of increasing vascular microcirculation, and the mechanisms of action of Finasteride and Dutasteride through 5-alpha reductase enzyme blockade and DHT reduction.<\/p>\r\n        <\/div>\r\n\r\n        <!-- Hekimler \u0130\u00e7in Klinik K\u0131lavuz (B\u00f6l\u00fcm 1) -->\r\n        <section class=\"doctor-guide-box\">\r\n            <h3>\ud83e\ude7a Clinical & Medical Guide for Physicians<\/h3>\r\n            <ul class=\"styled-list doctor-list\">\r\n                <li><strong>Etiology and Pharmacological Approach:<\/strong> Targeting androgenic and vascular factors involved in hair follicle miniaturization. Supporting follicular cell proliferation. <\/li>\r\n                <li><strong>Topical and Systemic Agents:<\/strong>\r\n                    <ul class=\"sub-list\">\r\n                        <li><em>Minoxidil (2% and 5%):<\/em> Topical and low-dose oral formulations that prolong the anagen phase and increase hair shaft diameter by enhancing vascular endothelial growth factor (VEGF) release.<\/li>\r\n                        <li><em>5-Alpha Reductase Inhibitors:<\/em> Systemic agents (finasteride\/dutasteride) that suppress the conversion of testosterone to dihydrotestosterone (DHT) in male-pattern hair loss.<\/li>\r\n                    <\/ul>\r\n                <\/li>\r\n            <\/ul>\r\n        <\/section>\r\n\r\n        <!-- 2. G\u00f6rsel: Kad\u0131n Tipi Sa\u00e7 D\u00f6k\u00fclmesinde Antiandrojen Tedavi -->\r\n        <div class=\"medical-illustration-box\" style=\"margin-top: 40px;\">\r\n            <img decoding=\"async\" src=\"https:\/\/muhammetozgehan.com\/wp-content\/uploads\/2026\/10\/dr-muhammet-ozgehan-kadin-tipi-sac-dokulmesi-anti-androjen-tedavi.png\" alt=\"Antiandrogen Treatment in Female-Pattern Hair Loss \u2013 Dr. Muhammet \u00d6zgehan\" title=\"\">\r\n            <p class=\"illustration-caption\">Figure 2: Antiandrogen agents such as spironolactone and cyproterone acetate in female-pattern hair loss, showing their pathways of follicular receptor blockade and hormonal regulation.<\/p>\r\n        <\/div>\r\n\r\n        <!-- Hekimler \u0130\u00e7in Klinik K\u0131lavuz (B\u00f6l\u00fcm 2) -->\r\n        <section class=\"doctor-guide-box\">\r\n            <ul class=\"styled-list doctor-list\" style=\"margin-top: 0;\">\r\n                <li><strong>Antiandrogens (For Female Patients):<\/strong> Management of agents such as spironolactone, cyproterone acetate, or flutamide in female patients with signs of hyperandrogenism (acne, hirsutism, etc.) through androgen receptor blockade and ovarian\/adrenal androgen suppression.<\/li>\r\n                <li><strong>Clinical Follow-up and Combination Management:<\/strong> Optimization of single pharmacological agents according to the patient's etiological profile. Periodic monitoring of hair diameter and density measurements with digital trichoscopy. Additionally, <a href=\"https:\/\/www.muhammetozgehan.com.tr\" target=\"_blank\" rel=\"noopener\">expertise and treatment approaches<\/a> can be reviewed for clinical and surgical evaluations.  <\/li>\r\n            <\/ul>\r\n        <\/section>\r\n\r\n        <!-- Bilimsel Referanslar -->\r\n        <section class=\"scientific-references-box\">\r\n            <h3>Scientific References and Bibliography<\/h3>\r\n            <ul class=\"ref-list\">\r\n                <li>Gupta AK, Talukder M, Williams G. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia. <em>J Dermatolog Treat.<\/em> 2022 Nov;33(7):2946-2962. doi: 10.1080\/09546634.2022.2109567. Epub 2022 Aug 15. PMID: 35920739. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35920739\/\" target=\"_blank\" rel=\"noopener\">PubMed Link<\/a><\/li>\r\n                <li>Gupta AK, Talukder M, Shemer A. Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia. <em>Expert Opin Pharmacother.<\/em> 2024 Feb;25(2):139-147. doi: 10.1080\/14656566.2024.2314087. Epub 2024 Feb 6. PMID: 38315101.<\/li>\r\n                <li>Seyed Jafari SM, Heidemeyer K, Hunger RE, de Viragh PA. Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies. <em>J Clin Med.<\/em> 2024 May 23;13(11):3052. doi: 10.3390\/jcm13113052. PMID: 38892763; PMCID: PMC11172682. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38892763\/\" target=\"_blank\" rel=\"noopener\">PubMed Link<\/a> <\/li>\r\n                <li>Arif T, Dorjay K, Adil M, Sami M. Dutasteride in Androgenetic Alopecia: An Update. <em>Curr Clin Pharmacol.<\/em> 2017;12(1):31-35. doi: 10.2174\/1574884712666170310111125. PMID: 28294070. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28294070\/\" target=\"_blank\" rel=\"noopener\">PubMed Link<\/a><\/li>\r\n                <li>Motofei IG, Rowland DL, Baconi DL, et al. Androgenetic alopecia; drug safety and therapeutic strategies. <em>Expert Opin Drug Saf.<\/em> 2018 Apr;17(4):407-412. doi: 10.1080\/14740338.2018.1430765. PMID: 29363345. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29363345\/\" target=\"_blank\" rel=\"noopener\">PubMed Link<\/a> <\/li>\r\n                <li>Varothai S, Shapiro MY. Edema and accelerated hair growth.   <em>J Am Acad Dermatol.<\/em>  2013;69(3):331-340.<\/li>\r\n            <\/ul>\r\n        <\/section>\r\n    <\/article>\r\n<\/div>\r\n\r\n<style>\r\n.medical-guide-page-wrapper {\r\n    background-color: #0A192F;\r\n    padding: 60px 20px;\r\n    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;\r\n    color: #FFFFFF;\r\n    max-width: 1000px;\r\n    margin: 0 auto;\r\n}\r\n\r\n.guide-hero {\r\n    text-align: center;\r\n    margin-bottom: 40px;\r\n}\r\n\r\n.hero-title-wrapper {\r\n    display: flex;\r\n    align-items: center;\r\n    justify-content: center;\r\n    gap: 12px;\r\n    margin-bottom: 10px;\r\n}\r\n\r\n.hero-logo-box {\r\n    background: linear-gradient(135deg, rgba(17, 34, 64, 0.9), rgba(10, 25, 47, 0.95));\r\n    border: 1px solid rgba(212, 175, 55, 0.4);\r\n    border-radius: 8px;\r\n    padding: 4px 8px;\r\n    display: flex !important;\r\n    align-items: center !important;\r\n    justify-content: center !important;\r\n    width: 44px !important;\r\n    height: 44px !important;\r\n    box-shadow: 0 4px 15px rgba(0,0,0,0.3);\r\n    flex-shrink: 0;\r\n}\r\n\r\n.hero-inline-logo {\r\n    width: 32px !important;\r\n    height: 32px !important;\r\n    max-width: 32px !important;\r\n    max-height: 32px !important;\r\n    object-fit: contain !important;\r\n}\r\n\r\n.guide-subtitle {\r\n    color: #CBD5E1;\r\n    font-size: 15px;\r\n    margin: 0;\r\n}\r\n\r\n.medical-article-card {\r\n    background: linear-gradient(135deg, rgba(17, 34, 64, 0.85), rgba(10, 25, 47, 0.95));\r\n    border: 1px solid rgba(212, 175, 55, 0.3);\r\n    border-radius: 16px;\r\n    padding: 40px;\r\n    box-shadow: 0 10px 30px rgba(0,0,0,0.4);\r\n}\r\n\r\n.article-header {\r\n    border-bottom: 1px solid rgba(212, 175, 55, 0.2);\r\n    padding-bottom: 25px;\r\n    margin-bottom: 30px;\r\n}\r\n\r\n.article-category {\r\n    display: inline-block;\r\n    color: #D4AF37;\r\n    font-size: 10px;\r\n    font-weight: 700;\r\n    text-transform: uppercase;\r\n    letter-spacing: 2px;\r\n    background: rgba(212, 175, 55, 0.1);\r\n    padding: 4px 10px;\r\n    border-radius: 4px;\r\n    margin-bottom: 15px;\r\n}\r\n\r\n.medical-article-card h1 {\r\n    font-size: 28px;\r\n    color: #FFFFFF;\r\n    margin: 0 0 15px 0;\r\n    font-weight: 700;\r\n    line-height: 1.3;\r\n}\r\n\r\n.author-meta-box p {\r\n    font-size: 14px;\r\n    color: #CBD5E1;\r\n    margin: 3px 0;\r\n}\r\n\r\n.compilation-note {\r\n    color: #94A3B8;\r\n    font-size: 13px;\r\n}\r\n\r\n.medical-illustration-box {\r\n    margin: 30px 0;\r\n    text-align: center;\r\n    background: rgba(0, 0, 0, 0.2);\r\n    padding: 15px;\r\n    border-radius: 10px;\r\n    border: 1px solid rgba(255, 255, 255, 0.05);\r\n}\r\n\r\n.medical-illustration-box img {\r\n    max-width: 100%;\r\n    height: auto;\r\n    border-radius: 8px;\r\n    box-shadow: 0 4px 15px rgba(0,0,0,0.3);\r\n}\r\n\r\n.illustration-caption {\r\n    font-size: 13px;\r\n    color: #94A3B8;\r\n    margin-top: 10px;\r\n    font-style: italic;\r\n}\r\n\r\n.patient-info-box, .doctor-guide-box, .scientific-references-box {\r\n    margin-top: 35px;\r\n    background: rgba(10, 25, 47, 0.6);\r\n    border: 1px solid rgba(212, 175, 55, 0.2);\r\n    border-radius: 12px;\r\n    padding: 25px;\r\n}\r\n\r\n.medical-article-card h3 {\r\n    font-size: 18px;\r\n    color: #D4AF37;\r\n    margin-top: 0;\r\n    margin-bottom: 15px;\r\n    font-weight: 600;\r\n}\r\n\r\n.medical-article-card p, .medical-article-card li {\r\n    font-size: 14px;\r\n    color: #CBD5E1;\r\n    line-height: 1.6;\r\n}\r\n\r\n.styled-list {\r\n    padding-left: 20px;\r\n    margin: 10px 0;\r\n}\r\n\r\n.styled-list li {\r\n    margin-bottom: 10px;\r\n}\r\n\r\n.sub-list {\r\n    margin-top: 8px;\r\n    padding-left: 20px;\r\n    list-style-type: circle;\r\n}\r\n\r\n.scientific-references-box {\r\n    border-top: 1px solid rgba(212, 175, 55, 0.3);\r\n}\r\n\r\n.ref-list {\r\n    padding-left: 20px;\r\n    font-size: 13px;\r\n    color: #94A3B8;\r\n}\r\n\r\n.ref-list li {\r\n    margin-bottom: 12px;\r\n}\r\n\r\n.medical-article-card a {\r\n    color: #D4AF37;\r\n    text-decoration: underline;\r\n    transition: color 0.3s ease;\r\n}\r\n\r\n.medical-article-card a:hover {\r\n    color: #f3d06c;\r\n}\r\n\r\n\/* Mobil Uyumluluk *\/\r\n@media (max-width: 768px) {\r\n    .medical-article-card {\r\n        padding: 20px;\r\n    }\r\n    .medical-article-card h1 {\r\n        font-size: 22px;\r\n    }\r\n}\r\n<\/style>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Medical Hair Encyclopedia Dermatological pathologies and evidence-based clinical guidelines at international standards. HAIR TREATMENTS &#038; MEDICAL APPROACH Medical Treatments (Pharmacological and Topical Solutions) \u2013 Clinical Management Guide Prepared by: Dr. Muhammet \u00d6zgehan | Turkish Hair and Scalp Diseases Association This guide is compiled by Dr. Muhammet \u00d6zgehan in conjunction with current trichology literature. \ud83d\udccc Patient [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1193","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/muhammetozgehan.com\/en\/wp-json\/wp\/v2\/pages\/1193","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/muhammetozgehan.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/muhammetozgehan.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/muhammetozgehan.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/muhammetozgehan.com\/en\/wp-json\/wp\/v2\/comments?post=1193"}],"version-history":[{"count":0,"href":"https:\/\/muhammetozgehan.com\/en\/wp-json\/wp\/v2\/pages\/1193\/revisions"}],"wp:attachment":[{"href":"https:\/\/muhammetozgehan.com\/en\/wp-json\/wp\/v2\/media?parent=1193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}